tachycardia - HEALTHIES
MarketWatch: AOP Health US LLC: RAPIBLYK(R) (landiolol) Approved by FDA for Use in Pediatric Patients with Supraventricular Tachycardia AOP Health US LLC: RAPIBLYK(R) (landiolol) Approved by FDA for Use in Pediatric Patients with Supraventricular Tachycardia People: What to Know About Ventricular Tachycardia and Myotonic Dystrophy, Gilbert Gottfried's 'Long Illness' What to Know About Ventricular Tachycardia and Myotonic Dystrophy, Gilbert Gottfried's 'Long Illness' Monomorphic ventricular tachycardia is an irregular heartbeat where the bottom chambers of your heart beat quicker than usual. It can cause symptoms such as shortness of breath, dizziness, or fatigue. This page lists all known medications that could potentially lead to 'Tachycardia nervous' as a side effect.
Understanding the Context
It's important to note that mild side effects are quite common with medications. The ... Patients suffering from refractory ventricular tachycardia, a life-threating heart condition, who are not suitable for existing treatment options now have another potential avenue for recovery thanks ... Among cancer patients who have tachycardia but who have not had a medical condition that is associated with tachycardia, such as pulmonary disease or thyroid disease, overall mortality risk is ...
Image Gallery
Key Insights
Yahoo Finance: AOP Health US LLC: RAPIBLYK® (landiolol) Approved by FDA for Use in Pediatric Patients with Supraventricular Tachycardia AOP Health US LLC: RAPIBLYK® (landiolol) Approved by FDA for Use in Pediatric Patients with Supraventricular Tachycardia